electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore(TM) nVNS for PTSD

Stock Information for electroCore Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About electroCore Inc.

electroCore to Announce First Quarter March 31, 2026, Financial Results on Wednesday, May 6, 2026
electroCore to Present at the Market Movers Investor Summit on May 5, 2026
electroCore Product Line Featured in Documentary Underscoring the Expanding Clinical and Commercial Role of Vagus Nerve Stimulation
electroCore to Participate in the 25th Annual Needham Virtual Healthcare Conference
electroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSD
electroCore Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
electroCore Expands Intellectual Property Portfolio
electroCore Announces Full Year 2025 Financial Results and Organizational Changes

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.